TRIM59 is a Novel Marker of Poor Prognosis and Promotes Malignant Progression of Ovarian Cancer by Inducing Annexin A2 Expression : Erratum

You Wang,Zhicheng Zhou,Xinran Wang,Xuping Zhang,Yansu Chen,Jin Bai,Wen Di

DOI: https://doi.org/10.7150/ijbs.69329

2022-01-01

International Journal of Biological Sciences

Abstract:[This corrects the article DOI: 10.7150/ijbs.28757.].

What problem does this paper attempt to address?

Erratum: Preoperative immunological plasma markers TRAIL, CSF1, and TIE2 predict survival after resection for biliary tract cancer

Frontiers Production Office

DOI: https://doi.org/10.3389/fonc.2023.1281693

2023-09-27

Abstract:[This corrects the article DOI: 10.3389/fonc.2023.1169537.].
[Corrigendum] Tripartite motif‐containing 11 regulates the proliferation and apoptosis of breast cancer cells

Xianping Dai,Feng Geng,Mengshun Li,Ming Liu

DOI: https://doi.org/10.3892/or.2024.8838

2024-11-08

Oncology Reports

Abstract:Subsequently to the publication of the above paper, an interested reader drew to the authors' attention that, concerning the flow cytometric plots shown in Fig. 5A and B on p. 2572, each figure part contained a pair of duplicated data panels; specifically, the panels depicting the 'NC/5‐FU' and the 'shTRIM11/Gemcitabine' experiments in Fig 5A (MCF‐7 cells), and the 'NC/Paclitaxel' and 'shTRIM11/Adriamycin' experiments in Fig. 5B (MDA‐MB‐231 cells), were apparently identical. The authors were able to re‐examine their original data files, and realize that this figure was inadverently assembled incorrectly. The revised version of Fig. 5, now showing the correct data for the 'shTRIM11/Gemcitabine' experiment in Fig 5A and the 'NC/Paclitaxel' experiment in Fig. 5B, is shown on the next page. Note that the revisions made to this figure do not affect the overall conclusions reported in the paper. The authors are grateful to the Editor of Oncology Reports for allowing them the opportunity to publish this Corrigendum, and apologize to the readership for any inconvenience caused. [Oncology Reports 41: 2567‐2574, 2019; DOI: 10.3892/or.2019.7015]

oncology
Corrigendum: High expression of PARP1 in tumor and stroma cells predicts prognosis and platinum resistance in patients with advanced epithelial ovarian cancer

Wei-Wei Zuo,Chun-Fang Zhao,Yan Li,Hai-Yan Sun,Guo-Ming Ma,Yue-Ping Liu,Shan Kang

DOI: https://doi.org/10.3389/fonc.2023.1218746

IF: 4.7

2023-06-27

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.931445.].

oncology
Corrigendum: Downregulation of GLYAT Facilitates Tumor Growth and Metastasis and Poor Clinical Outcomes Through the PI3K/AKT/Snail Pathway in Human Breast Cancer

Xin Tian,Lina Wu,Min Jiang,Zhenyong Zhang,Rong Wu,Jianing Miao,Caigang Liu,Song Gao

DOI: https://doi.org/10.3389/fonc.2022.793448

IF: 4.7

2022-04-06

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.641399.].

oncology
Correction To: Early Presence of Anti-Angiogenesis-related Adverse Events As a Potential Biomarker of Antitumor Efficacy in Metastatic Gastric Cancer Patients Treated with Apatinib: a Cohort Study

Xinyang Liu,Shukui Qin,Zhichao Wang,Jianming Xu,Jianping Xiong,Yuxian Bai,Zhehai Wang,Yan Yang,Guoping Sun,Liwei Wang,Leizhen Zheng,Nong Xu,Ying Cheng,Weijian Guo,Hao Yu,Tianshu Liu,Pagona Lagiou,Jin Li

DOI: https://doi.org/10.1186/s13045-017-0545-5

IF: 28.5

2017-01-01

Journal of Hematology & Oncology

Abstract:The original article [1] contains two errors in Table 2
High Expression of Cancer-Derived Glycosylated Immunoglobulin G Predicts Poor Prognosis in Pancreatic Ductal Adenocarcinoma: Erratum

Ming Cui,Lei You,Bang Zheng,Xinmei Huang,Qiaofei Liu,Jing Huang,Boju Pan,Xiaoyan Qiu,Quan Liao,Yupei Zhao

DOI: https://doi.org/10.7150/jca.32930

IF: 3.9

2021-01-01

Journal of Cancer

Abstract:[This corrects the article DOI: 10.7150/jca.39800.].
Corrigendum: CORO1C is Associated with Poor Prognosis and Promotes Metastasis Through PI3K/AKT Pathway in Colorectal Cancer

Zongxia Wang,Lizhou Jia,Yushu sun,Chunli Li,Lingli Zhang,Xiangcheng Wang,Hao Chen

DOI: https://doi.org/10.3389/fmolb.2021.727347

IF: 6.113

2021-08-30

Frontiers in Molecular Biosciences

Abstract:[This corrects the article DOI: 10.3389/fmolb.2021.682594.].

biochemistry & molecular biology
Corrigendum: Biomarking and induction of apoptosis in ovarian cancer using bifunctional polyethyleneimine-caged platinum nanoclusters

Mengjun Zhang,Haodi Yue,Yuan Liu,Hao Li,Yue Yin,Zhenxing Sun,Ping Cui,Fei Li,Xiuwei Chen,Xin Huang

DOI: https://doi.org/10.3389/fonc.2022.983959

IF: 4.7

2022-07-20

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.898917.].

oncology
Corrigendum: EXOSC5 As a Novel Prognostic Marker Promotes Proliferation of Colorectal Cancer Via Activating the ERK and AKT Pathways

Hongda Pan,Jingxin Pan,Shibo Song,Lei Ji,Hong Lv,Zhangru Yang

DOI: https://doi.org/10.3389/fonc.2021.670041

IF: 4.7

2021-01-01

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2019.00643.].
Corrigendum to “overexpression of GRK3, Promoting Tumor Proliferation, is Predictive of Poor Prognosis in Colon Cancer”

Tao Jiang,Chun Yang,Liyuan Ma,Zehua Wu,Ling Ye,Xiaoqiang Ma,Hai Li,Junwei Fan,Yinxue Yang

DOI: https://doi.org/10.1155/2020/1245645

2020-01-01

Disease Markers

Abstract:[This corrects the article DOI: 10.1155/2017/1202710.].
Corrigendum: Development and validation of a prognostic nomogram based on DNA methylation-driven genes for patients with ovarian cancer

Min Zhou,Shasha Hong,Bingshu Li,Cheng Liu,Ming Hu,Jie Min,Jianming Tang,Li Hong

DOI: https://doi.org/10.3389/fgene.2022.951409

IF: 3.7

2022-08-15

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2021.675197.].

genetics & heredity
Correction: Up-Regulation of 91H Promotes Tumor Metastasis and Predicts Poor Prognosis for Patients with Colorectal Cancer.

Qiwen Deng,Bangshun He,Tianyi Gao,Yuqin Pan,Huiling Sun,Yeqiong Xu,Rui Li,Houqun Ying,Feng Wang,Xian Liu,Jie Chen,Shukui Wang

DOI: https://doi.org/10.1371/journal.pone.0304249

IF: 3.7

2024-01-01

PLoS ONE

Abstract:[This corrects the article DOI: 10.1371/journal.pone.0103022.].
Erratum: MicroRNA-449a Inhibits Tumor Metastasis through AKT/ERK1/2 Inactivation by Targeting Steroid Receptor Coactivator (SRC) in Endometrial Cancer: Erratum.

Yuan Hu,An-Yue Wu,Cong Xu,Ke-Qi Song,Wen-Jing Wang,Xia Yin,Wen Di,Zu-Bei Hong,Li-Hua Qiu

DOI: https://doi.org/10.7150/jca.92673

IF: 3.9

2023-01-01

Journal of Cancer

Abstract:[This corrects the article DOI: 10.7150/jca.27748.].
Correction: TRIM58 downregulation maintains stemness via MYH9-GRK3-YAP axis activation in triple-negative breast cancer stem cells

Xujun Li,Jing Jiang,Qian Wu,Tianzi You,Fan Yang

DOI: https://doi.org/10.1038/s41417-024-00798-0

IF: 5.854

2024-06-25

Cancer Gene Therapy

Abstract:Cancer Gene Therapy, Published online: 25 June 2024; doi:10.1038/s41417-024-00798-0 Correction: TRIM58 downregulation maintains stemness via MYH9-GRK3-YAP axis activation in triple-negative breast cancer stem cells

oncology,genetics & heredity,medicine, research & experimental,biotechnology & applied microbiology
Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma: Erratum

Libin Yan,Beichen Ding,Haoran Liu,Yangjun Zhang,Jin Zeng,Junhui Hu,Weimin Yao,Gan Yu,Ruihua An,Zhiqiang Chen,Zhangqun Ye,Jinchun Xing,Kefeng Xiao,Lily Wu,Hua Xu

DOI: https://doi.org/10.7150/thno.68810

IF: 11.6

2022-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.37628.].

medicine, research & experimental
Corrigendum: Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K–AKT Pathway and Activating the AMPK–ROS Pathway

Xuan Wei,Juanjuan Shi,Qianhan Lin,Xiaoxue Ma,Yingxin Pang,Hongluan Mao,Rui Li,Wei Lu,Yu Wang,Peishu Liu

DOI: https://doi.org/10.3389/fonc.2021.742374

IF: 4.7

2021-09-07

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.642229.].

oncology
Erratum: circPTCH1 promotes invasion and metastasis in renal cell carcinoma via regulating miR-485-5p/MMP14 axis: Erratum.

Huan Liu,Guanghui Hu,Zaoyu Wang,Qunlong Liu,Jin Zhang,Yonghui Chen,Yiran Huang,Wei Xue,Yunfei Xu,Wei Zhai

DOI: https://doi.org/10.7150/thno.69378

IF: 11.6

2022-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.47239.].
Corrigendum to “ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma”

TingAn Wang,HuaGe Zhong,YuZhou Qin,WeiYuan Wei,Zhao Li,MingWei Huang,XiaoLing Luo

DOI: https://doi.org/10.1155/2021/3179693

2021-02-09

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2020/3575038.].

biotechnology & applied microbiology,medicine, research & experimental
Corrigendum: Identification of BRCA1:c.5470_5477del as a Founder Mutation in Chinese Ovarian Cancer Patients

Jun Li,Sile Han,Cuiyun Zhang,Yanlin Luo,Li Wang,Ping Wang,Yi Wang,Qingxin Xia,Xiaoyan Wang,Bing Wei,Jie Ma,Hongle Li,Yongjun Guo

DOI: https://doi.org/10.3389/fonc.2021.840551

IF: 4.7

2022-01-14

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.655709.].

oncology
Corrigendum: Neoadjuvant Tislelizumab Combined with Chemotherapy in Locally Advanced Oral or Oropharyngeal Squamous Cell Carcinoma: a Real-World Retrospective Study.

Wen-Jie Wu,Qian Liu,Pu-Gen An,Lin Wang,Jian-Yun Zhang,Yan Chen,Tong Zhang,Jie Zhang

DOI: https://doi.org/10.3389/fimmu.2023.1346845

IF: 7.3

2024-01-01

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1282629.].

TRIM59 is a Novel Marker of Poor Prognosis and Promotes Malignant Progression of Ovarian Cancer by Inducing Annexin A2 Expression : Erratum

Erratum: Preoperative immunological plasma markers TRAIL, CSF1, and TIE2 predict survival after resection for biliary tract cancer

[Corrigendum] Tripartite motif‐containing 11 regulates the proliferation and apoptosis of breast cancer cells

Corrigendum: High expression of PARP1 in tumor and stroma cells predicts prognosis and platinum resistance in patients with advanced epithelial ovarian cancer

Corrigendum: Downregulation of GLYAT Facilitates Tumor Growth and Metastasis and Poor Clinical Outcomes Through the PI3K/AKT/Snail Pathway in Human Breast Cancer

Correction To: Early Presence of Anti-Angiogenesis-related Adverse Events As a Potential Biomarker of Antitumor Efficacy in Metastatic Gastric Cancer Patients Treated with Apatinib: a Cohort Study

High Expression of Cancer-Derived Glycosylated Immunoglobulin G Predicts Poor Prognosis in Pancreatic Ductal Adenocarcinoma: Erratum

Corrigendum: CORO1C is Associated with Poor Prognosis and Promotes Metastasis Through PI3K/AKT Pathway in Colorectal Cancer

Corrigendum: Biomarking and induction of apoptosis in ovarian cancer using bifunctional polyethyleneimine-caged platinum nanoclusters

Corrigendum: EXOSC5 As a Novel Prognostic Marker Promotes Proliferation of Colorectal Cancer Via Activating the ERK and AKT Pathways

Corrigendum to “overexpression of GRK3, Promoting Tumor Proliferation, is Predictive of Poor Prognosis in Colon Cancer”

Corrigendum: Development and validation of a prognostic nomogram based on DNA methylation-driven genes for patients with ovarian cancer

Correction: Up-Regulation of 91H Promotes Tumor Metastasis and Predicts Poor Prognosis for Patients with Colorectal Cancer.

Erratum: MicroRNA-449a Inhibits Tumor Metastasis through AKT/ERK1/2 Inactivation by Targeting Steroid Receptor Coactivator (SRC) in Endometrial Cancer: Erratum.

Correction: TRIM58 downregulation maintains stemness via MYH9-GRK3-YAP axis activation in triple-negative breast cancer stem cells

Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma: Erratum

Corrigendum: Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K–AKT Pathway and Activating the AMPK–ROS Pathway

Erratum: circPTCH1 promotes invasion and metastasis in renal cell carcinoma via regulating miR-485-5p/MMP14 axis: Erratum.

Corrigendum to “ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma”

Corrigendum: Identification of BRCA1:c.5470_5477del as a Founder Mutation in Chinese Ovarian Cancer Patients

Corrigendum: Neoadjuvant Tislelizumab Combined with Chemotherapy in Locally Advanced Oral or Oropharyngeal Squamous Cell Carcinoma: a Real-World Retrospective Study.